S8 - Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): Cerebrovascular Disease and Interventional Neurology
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Impact of hyperglycemia according to collateral status on reperfusion and outcomes in acute ischemic stroke after mechanical thrombectomy Joon-Tae Kim
Dr. KIM has nothing to disclose.

3:42 PM 002 Ultra-short door-to-needle times of 10 minutes or less in stroke thrombolysis – experience from 63 cases Raffi Topakian, MD
Dr. Topakian has received personal compensation for activities with Novartis and Shire-Baxalta as an advisory board member, from Novartis, Pfizer, Abbvie, and Bayer for conference support, and from Pfizer as a speaker.

3:54 PM 003 Impact of Neurologist In-Hospital 24/7 on stroke patients arriving to the Emergency Department activated as a Code Stroke Alexander Schneider, MD
Dr. Schneider has nothing to disclose.

4:06 PM 004 An analysis of fixed dose IV recombinant tissue plasminogen activator (rtPA) and clinical outcomes in acute ischemic stroke patients with body weight >100 kilograms: pooled data from three randomized clinical trials Shahram Majidi, MD
Dr. Majidi has nothing to disclose.

4:18 PM 005 The effect of baseline blood pressure on the benefit and safety of intra-arterial treatment in MR CLEAN. Maxim Mulder
Dr. Mulder has nothing to disclose.

4:30 PM 006 Reliability of automated software to assign e-ASPECTS to CT scans for acute ischemic changes Lisa C Hoyte
Dr. Hoyte has nothing to disclose.

4:42 PM 007 Thrombectomy and thrombolysis in pediatric acute ischemic stroke Kathryn Ess, MD
Dr. Ess has nothing to disclose.

4:54 PM 008 Disruption of the Blood-Ocular Barriers in Stroke Patients Emi Hitomi
Dr. Hitomi has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses